Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2018 Jul 11;99(1):56-63.e3.
doi: 10.1016/j.neuron.2018.06.030.

Alzheimer's Disease-Associated β-Amyloid Is Rapidly Seeded by Herpesviridae to Protect against Brain Infection

Affiliations

Alzheimer's Disease-Associated β-Amyloid Is Rapidly Seeded by Herpesviridae to Protect against Brain Infection

William A Eimer et al. Neuron. .

Erratum in

Abstract

Amyloid-β peptide (Aβ) fibrilization and deposition as β-amyloid are hallmarks of Alzheimer's disease (AD) pathology. We recently reported Aβ is an innate immune protein that protects against fungal and bacterial infections. Fibrilization pathways mediate Aβ antimicrobial activities. Thus, infection can seed and dramatically accelerate β-amyloid deposition. Here, we show Aβ oligomers bind herpesvirus surface glycoproteins, accelerating β-amyloid deposition and leading to protective viral entrapment activity in 5XFAD mouse and 3D human neural cell culture infection models against neurotropic herpes simplex virus 1 (HSV1) and human herpesvirus 6A and B. Herpesviridae are linked to AD, but it has been unclear how viruses may induce β-amyloidosis in brain. These data support the notion that Aβ might play a protective role in CNS innate immunity, and suggest an AD etiological mechanism in which herpesviridae infection may directly promote Aβ amyloidosis.

Keywords: Alzheimer’s disease; amyloid-β; antimicrobial peptide; herpes simplex virus 1; herpesviridae; herpesvirus glycoprotein; human herpesvirus 6; infection; oligomers; β-amyloid peptide.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.. Aβ 42 expression increases host survival in a HSV1 encephalitis 5XFAD mouse model.
Transgenic mice (5XFAD) expressing human Aβ were compared against wild type (WT) littermates for survival following bilateral intracranial injections of HSV1. Following injection of viable HSV1, WT and 5XFAD mice were followed for (a) survival and (b) weight loss. No mortality was observed among sham-infected control. Statistical significance was calculated by log-rank (Mantel-Cox) test for survival and statistical means compared by t-test for weight loss. Survival analysis data were pooled from five independent experiments.
Figure 2.
Figure 2.. Cell-derived Aβ 42 oligomers mediate HSV1 resistance in cell culture monolayer infection models.
Confluent human H4-N cell monolayers were co-incubated (2 hrs) with HSV1-RFP fusion virus and conditioned media from transformed H4-Aβ42 (H4-Aβ42) or CHO-Aβ (CHO-Aβ) cells, anti-Aβ immunodepleted (ID) H4-Aβ42 (ID H4-Aβ42) and CHO-Aβ (ID CHO-Aβ) media, and synthetic (Aβ42) or scrambled (scAβ42) peptides treated to disrupt soluble oligomeric species. Host cell HSV1-RDP infection was assayed by flow cytometry. Signal shown as percentage of naïve H4-N, CHO-N, or unconditioned media for H4-Aβ42, CHO-Aβ, and Aβ peptides, respectively. Bars are mean signal of replicates (n=6) ± SEM. Statistical mean comparisons of naïve and transformed signal were by t-test. Flow cytometry gating strategy shown in supplemental figure 7. Data are representative of at least 6 independent experiments for each condition.
Figure 3.
Figure 3.. Aβ heparin-binding activity mediates binding of herpesviridae glycoproteins.
Aβ binding to heat-immobilized intact whole HSV1 particles was characterized in an Aβ-binding ELISA. (a) Wells containing immobilized HSV1 were incubated with transformed cell conditioned media (CHO-CAB) or synthetic Aβ42 (12.5 μg/ml) peptide (Syn Aβ42) alone or with mannan (+Mannan), or negative control anti-Aβ immunodepleted media (CHO-CAB ID), and probed for anti-Aβ signal. (b) HSV1 wells were pre-incubated with antibodies against HSV1 surface glycoproteins B (α-gB), C (α-gC), D (α-gD), E (α-gE), G (α-gG), and H (α-gH) then incubated with H4-Aβ42 conditioned media. Signal shown as percentage of naïve CHO-N or unconditioned media for CHO-CAB and Aβ peptides, respectively. Bars are mean signal of replicates (n=6) ± SEM. Statistical mean comparisons were done by t-test. Panels show data representative of finding from at least 8 independent experiments.
Figure 4.
Figure 4.. Aβ fibrilization mediates viral entrapment in 3D human stem cell-derived neural cell culture and 5XFAD mouse infection models.
Aβ fibrillization with HSV1 (HSV1), HHV6A (HHV6A), or HHV6B (HHV6B) infection was characterized in 3D cultures of GFP-expressing human neurons (host cells) and AD mouse models. Cell cultures and mouse brain sections were immunoprobed with anti-HSV1 (α-HSV1), anti-gB (α-gB), or anti-Aβ (α-Aβ) fluorophore labeled antibodies, and analyzed for green (GFP), red (RFP), and blue (405) fluorescence by confocal microscopy. (a) Virus preparations were incubated for 15, 30 or 120 min in H4-Aβ42 conditioned media and analyzed by TEM. (b and c) Three-week old 3D cell cultures were left untreated (Uninfected) or incubated (48 hrs) with virus and fluorescence signals captured under (b) low or (c) high magnification. (d and e) Wild-type (WT) and transgenic AD (5XFAD) mice were injected with HSV1 (+HSV1) or sterile vehicle (Uninfected) and brain sections immunoprobed for HSV1 and Aβ and stained for β-amyloid (β-amyloid) with Thioflavin S (ThS). Panels show (d) wide-field signal from brain 72 hrs following injection with high (lethal) HSV1 titer and (e) high magnification image of Aβ deposits in 5XFAD brain 21 days post-administration of non-lethal viral dose. Panels are representative of multiple image fields (>20) captured for each experimental condition.

Comment in

References

    1. Alonso R, Pisa D, Marina AI, Morato E, Rabano A, and Carrasco L (2014). Fungal infection in patients with Alzheimer’s disease. J Alzheimers Dis 41, 301–311. - PubMed
    1. Araki-Sasaki K, Ando Y, Nakamura M, Kitagawa K, Ikemizu S, Kawaji T, Yamashita T, Ueda M, Hirano K, Yamada M, et al. (2005). Lactoferrin Glu561Asp facilitates secondary amyloidosis in the cornea. Br J Ophthalmol 89, 684–688. - PMC - PubMed
    1. Arnusch CJ, Branderhorst H, de Kruijff B, Liskamp RMJ, Breukink E, and Pieters RJ (2007). Enhanced membrane pore formation by multimeric/oligomeric antimicrobial peptides. Biochemistry 46, 13437–13442. - PubMed
    1. Bourgade K, Garneau H, Giroux G, Le Page AY, Bocti C, Dupuis G, Frost EH, and Fulop T Jr. (2015). β-Amyloid peptides display protective activity against the human Alzheimer’s disease-associated herpes simplex virus-1. Biogerontology 16, 85–98. - PubMed
    1. Bourgade K, Le Page A, Bocti C, Witkowski JM, Dupuis G, Frost EH, and Fulop T (2016). Protective Effect of Amyloid-β Peptides Against Herpes Simplex Virus-1 Infection in a Neuronal Cell Culture Model. J Alzheimers Dis 50, 1227–1241. - PubMed

Publication types

MeSH terms

Substances